Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (1): 53-57    DOI: 10.12891/ceog3785.2018
Original Research Previous articles | Next articles
Universal versus risk factor screening for gestational diabetes mellitus
A. Ferraiolo1, C. Bordone2, A. Ramone1, P. Sala1, *(), F. Gorlero3, C. Gustavino1, R. Cordera4
1 Unit of Obstetrics and Gynecology, IRCCS San Martino University Hospital, National Institute for Cancer Research, Genoa, Italy
2 Department of Internal Medicine (DIMI), IRCCS San Martino University Hospital, National Institute for Cancer Research, Genoa, Italy
3 Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa and Unit of Obstetrics and Gynecology, E.O. Ospedali Galliera, Genoa, Italy
4 Department of Internal Medicine (DIMI), University of Genoa and IRCCS San Martino University Hospital, National Institute for Cancer Research, Genoa, Italy
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Despite a general consensus about the importance of diagnosis and treatment of gestational diabetes mellitus (GDM), there is no agreement on screening criteria. The aim is to compare the performance of universal versus risk factor-based screening for GDM. Materials and Methods: The authors reviewed the medical records of 894 pregnant women, who were screened throughout 75 two-hour 75-gram oral glucose tolerance test (OGTT) between 24 and 28 weeks of gestation, from May 2012 to May 2014 at a single University Hospital. Each patient was evaluated for the presence of risk factors for GDM (age ≥ 35 years old, BMI ≥ 25 kg/m2, previous fetal macrosomia, a family history of type 2 diabetes mellitus, and high risk ethnicity). Results: Out of the 894 pregnant women, 150 (16.8%) were diagnosed with GDM according to the universal screening. Two hundred five women (22.9%) were at low risk for GDM, while 689 presented at least one or more risk factors. Using a risk factors based screening, 205 low-risk women would have skipped OGTT, but 19 of them (12.7% of women affected by GDM) received the diagnosis of GDM throughout OGTT. Nevertheless, risk factors showed a high strength as predictors of GDM diagnosis, with the exception of age ≥ 35 years. The comparison of maternal fetal outcomes between GDM women with or without risk factors presented no statistically significant differences. Conclusions: In the present authors' experience, the implementation of a risk factors based screening may lead to a reduction in the detection rate of GDM women.
Key words:  Gestational diabetes mellitus      Pregnancy      Screening     
Published:  10 February 2018     
*Corresponding Author(s):  P. SALA     E-mail:  paolsala@gmail.com

Cite this article: 

A. Ferraiolo, C. Bordone, A. Ramone, P. Sala, F. Gorlero, C. Gustavino, R. Cordera. Universal versus risk factor screening for gestational diabetes mellitus. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 53-57.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3785.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I1/53

[1] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[2] K. Chikazawa, K. Imai, T. Kuwata, K. Takagi. Prophylactic laparoscopic adnexal surgery with low-pressure CO2 insufflation for ovarian cysts during the late first trimester or second trimester of pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 537-540.
[3] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[4] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[5] A. Daniilidis, G. Dryllis, G. Chorozoglou, M. Politou, R. Dampali, K. Dinas. Substitution of hemoglobin levels in pregnant women with iron supplement: A prospective randomized clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 579-583.
[6] Z.Y. Chang, R. Cao, R.C. Xu, Y. Cheng, Q.J. Wan. Pregnancy in a peritoneal dialysis patient undergoing intermittent peritoneal dialysis during the third trimester of pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 596-599.
[7] C.Y. Huang, T.C. Chao, H.C. Chien, Y.L. Liu. Outcome of shared decision-making in a patient with primary herpes gingivostomatitis during pregnancy: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 604-606.
[8] G.L. Liu, S.C. He, W.J. Shan, H.Y. Chen. Repetitive hydatidiform mole in the cesarean scar: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 607-610.
[9] K. Nakanishi, Y. Oishi, T. Miyamoto, E. Nakamura, K. Murakami, M. Ono, A. Nozawa, S. Kitamura, K. Sengoku. Anti-E alloimmunization in a pregnancy with a low antibody titer[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 614-616.
[10] F. Wang, Z.X. Liang, W.R. Mao, S.N. He, D.Q. Chen. Influence of pre-pregnancy body mass index and gestational weight gain in twin pregnancies on blood glucose, serum lipid and perinatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 376-382.
[11] G. Keren, G. Ayala. Factors associated with hyperemesis gravidarum[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 391-395.
[12] H. Cokmez, C. Bayram. Pituitary apoplexy developing during pregnancy: escape from the verge of death[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 429-431.
[13] H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au. Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 438-441.
[14] Y.Q. Xu, X. L. Chen, S. Zhao, P. W. Chen, X. M. Yin, S. Y. Xiong, Z. Ding, F. Xiong, X. H. Yang. OEIS complex (omphalocele-exstrophy-imperforate anus-spinal defects) in monozygotic twins: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 154-158.
[15] H.F. Zhang, J. Zhang, D. Yang, S.N. Li. Clinical analysis of atrial fibrillation in pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 174-178.
No Suggested Reading articles found!